Combined genetic and pharmacological inhibition of TRPV1 and P2X3 attenuates colorectal hypersensitivity and afferent sensitization.
about
Experimental and computational evidence for an essential role of NaV1.6 in spike initiation at stretch-sensitive colorectal afferent endingsMultiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease-derived stimuli.Long-term upregulation of cortical glutamatergic AMPA receptors in a mouse model of chronic visceral pain.Enhanced binding capability of nuclear factor-κB with demethylated P2X3 receptor gene contributes to cancer pain in rats.Optogenetic activation of mechanically insensitive afferents in mouse colorectum reveals chemosensitivityThe nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptorsAnimal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges.P2X3 receptor-mediated visceral hyperalgesia and neuronal sensitization following exposure to PTSD-like stress in the dorsal root ganglia of rats.Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.In vitro functional characterization of mouse colorectal afferent endings.Roles of isolectin B4-binding afferents in colorectal mechanical nociception.Sex differences in primary muscle afferent sensitization following ischemia and reperfusion injury.TRPV1 enhances the afferent response to P2X receptor activation in the mouse urinary bladder.
P2860
Q30646640-E6B2AA5A-C978-41DB-AC61-E6BD7B888356Q34451600-5EB08746-AF81-470D-B750-73FBB2A88B29Q36301835-4FA2FACB-4ED1-4310-B957-D9FD5139AF89Q36628286-47944068-6F8E-4F78-A8B0-AA00E9267068Q36955291-00E9E1CC-0C96-49AA-8C35-FB2BEF541DE7Q37246699-7CF2E772-7CC3-46FC-B630-9435C58913DAQ38376282-8AB3EF17-891C-4EAC-8C30-A033FB1CB57CQ39249530-2C5EE68E-E7B1-4F64-9BC0-5E833E00D463Q41953953-8BFAAB24-9039-46C9-98E6-F9A01DE11BFFQ42029422-3DC27D1F-F666-4FBF-884D-2D7FAA6AB126Q43071880-A8BACA44-2014-41D1-B91D-A9456D1DB19EQ47147849-84FF115C-7E87-4CBE-99B4-B959FF284E1AQ49532787-DEC06485-7CBA-4349-9D18-3B6DC5448782
P2860
Combined genetic and pharmacological inhibition of TRPV1 and P2X3 attenuates colorectal hypersensitivity and afferent sensitization.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Combined genetic and pharmacol ...... ty and afferent sensitization.
@en
Combined genetic and pharmacol ...... ty and afferent sensitization.
@nl
type
label
Combined genetic and pharmacol ...... ty and afferent sensitization.
@en
Combined genetic and pharmacol ...... ty and afferent sensitization.
@nl
prefLabel
Combined genetic and pharmacol ...... ty and afferent sensitization.
@en
Combined genetic and pharmacol ...... ty and afferent sensitization.
@nl
P2093
P2860
P356
P1476
Combined genetic and pharmacol ...... ty and afferent sensitization.
@en
P2093
Erica S Schwartz
G F Gebhart
Michael E Kiyatkin
P2860
P304
P356
10.1152/AJPGI.00180.2013
P577
2013-08-29T00:00:00Z